| Financial Year |
March 31 2023 |
| Monetary Funds |
2,838,954,722.17 |
| Held-for-trading Financial Assets |
1,635,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
47,005,224.68 |
| Advances to Suppliers |
3,124,832.76 |
| Other Receivables |
10,153,029.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,089,294,014.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
70,000,000.00 |
| Other Current Assets |
1,680,585.83 |
| Total Current Assets |
6,695,212,409.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
34,030,183.12 |
| Long-term Equity Investment |
17,732,065.57 |
| Investment Properties |
767,520,742.32 |
| Fixed Assetes |
749,733,722.69 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,824,340.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,362,226.23 |
| Deferred Income Tax Assets |
390,489,034.80 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,180,593,736.08 |
| Total Assets |
8,875,806,145.49 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
304,844,774.29 |
| Accounts Received In Advance |
48,077,990.20 |
| Employee Compensation Payable |
2,015,981.55 |
| Taxes Payable |
134,405,729.01 |
| Interest Payable |
-- |
| Dividend Payable |
864,598.47 |
| Other payables |
1,378,873,873.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
47,736,474.67 |
| Other Current Liabilities |
1,653,487.29 |
| Sub-Total of Current Liabilities |
1,951,093,744.18 |
| Long-term Loans |
586,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
40,036,523.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
627,106,820.44 |
| Total Liabilities |
2,578,200,564.62 |
| Paid-In Capital(Or Share Stock) |
1,483,934,025.00 |
| Capital Surplus |
231,941,056.97 |
| Surplus Reserve |
567,845,733.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,051,275,572.52 |
| Minority Stockholder's Interest |
962,663,808.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,334,941,772.26 |
| Owner's Equity（Stockholder's Equity） |
6,297,605,580.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,875,806,145.49 |
